Dr. Adam Ritchie is the curriculum and course advisor for our Immunology program in Oxford. He is a vaccine developer and academic at the University of Oxford. Adam played a key role in the development of the Oxford-AstraZeneca COVID-19 vaccine, which saved over 6 million lives in 2021. He is currently working on vaccines to respond to the Ebola outbreak in Uganda, and to address the global burden of rabies and Epstein-Barr Virus.
Adam studied medical microbiology and immunology as an undergraduate, before completing a PhDin immunology at the University of New South Wales, Australia. He moved to the University ofOxford in 2005, and has done research on diseases such as HIV/AIDS, malaria and COVID-19, as well as working on policy, teaching and admissions. He has taught thousands of graduate, undergraduate and visiting students to Oxford. Adam completed a Post-Graduate Diploma in education in 2013, and has been awarded a Teaching Excellence Award by the University of Oxford.
A key aspect of Adam’s research is the translation of science and research into positive impacts on people’s lives. At the moment, this involves developing and manufacturing new vaccines, designing and carrying out clinical trials, analysing vaccine safety and efficacy, and developing processes to help get great academic research out of the lab and to those who can benefit from it most